Cargando…
Therapeutic advantages of combined gene/cell therapy strategies in a murine model of GM2 gangliosidosis
Genetic deficiency of β-N-acetylhexosaminidase (Hex) functionality leads to accumulation of GM2 ganglioside in Tay-Sachs disease and Sandhoff disease (SD), which presently lack approved therapies. Current experimental gene therapy (GT) approaches with adeno-associated viral vectors (AAVs) still pose...
Autores principales: | Sala, Davide, Ornaghi, Francesca, Morena, Francesco, Argentati, Chiara, Valsecchi, Manuela, Alberizzi, Valeria, Di Guardo, Roberta, Bolino, Alessandra, Aureli, Massimo, Martino, Sabata, Gritti, Angela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983315/ https://www.ncbi.nlm.nih.gov/pubmed/35434178 http://dx.doi.org/10.1016/j.omtm.2022.03.011 |
Ejemplares similares
-
Integrated Computational Analysis Highlights unique miRNA Signatures in the Subventricular Zone and Striatum of GM2 Gangliosidosis Animal Models
por: Morena, Francesco, et al.
Publicado: (2019) -
Combined gene/cell therapies provide long-term and pervasive rescue of multiple pathological symptoms in a murine model of globoid cell leukodystrophy
por: Ricca, Alessandra, et al.
Publicado: (2015) -
Genetics and Therapies for GM2 Gangliosidosis
por: Cachón-González, María Begoña, et al.
Publicado: (2018) -
GM1 Gangliosidosis: Mechanisms and Management
por: Rha, Allisandra K, et al.
Publicado: (2021) -
GM1 Gangliosidosis—A Mini-Review
por: Nicoli, Elena-Raluca, et al.
Publicado: (2021)